Serveur d'exploration sur le patient édenté

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

European school of oncology advisory report to the European Commission for the Europe against cancer programme: Oral carcinogenesis in Europe

Identifieur interne : 000460 ( France/Analysis ); précédent : 000459; suivant : 000461

European school of oncology advisory report to the European Commission for the Europe against cancer programme: Oral carcinogenesis in Europe

Auteurs : P. Boyle [Italie] ; G. J. Macfarlane [Italie] ; W. J. Blot [États-Unis] ; F. Chiesa [Italie] ; J. L. Lefebvre [France] ; A. Mano Azul [Portugal] ; N. De Vries [Pays-Bas] ; C. Scully

Source :

RBID : ISTEX:6285C86FE41880A49A3A76A1FB500602A9E625C5

Descripteurs français

English descriptors

Abstract

Abstract: A European School of Oncology Advisory Group has reviewed current knowledge on the epidemiology, treatment and prevention of cancer of the oral cavity. While the major factors in the aetiology of such cancers are thought to be well understood, i.e. tobacco and alcohol consumption, current increases in the occurrence of the disease, especially in young adults throughout Europe, are cause for concern. The reasons for such increases are not clearly evident and the Advisory Group has suggested further work which is required to be carried out to understand the aetiology. In treatment of the disease there have been no major improvements in survival for patients in recent decades and the importance of examining new radiotherapy modalities and defining the role of chemotherapy is emphasized. Primary prevention of oral cancer could be achieved by stopping smoking tobacco, limiting alcohol consumption to a minimum (2–3 drinks per day) and increasing intake of fruits and vegetables. To supplement these actions, while neither population screening programmes nor screening trials could be recommended by the Advisory Group, initial chemoprevention trials have produced some promising results and this represents an interesting area which is the focus of much current research.

Url:
DOI: 10.1016/0964-1955(95)00007-5


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:6285C86FE41880A49A3A76A1FB500602A9E625C5

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>European school of oncology advisory report to the European Commission for the Europe against cancer programme: Oral carcinogenesis in Europe</title>
<author>
<name sortKey="Boyle, P" sort="Boyle, P" uniqKey="Boyle P" first="P." last="Boyle">P. Boyle</name>
</author>
<author>
<name sortKey="Macfarlane, G J" sort="Macfarlane, G J" uniqKey="Macfarlane G" first="G. J." last="Macfarlane">G. J. Macfarlane</name>
</author>
<author>
<name sortKey="Blot, W J" sort="Blot, W J" uniqKey="Blot W" first="W. J." last="Blot">W. J. Blot</name>
</author>
<author>
<name sortKey="Chiesa, F" sort="Chiesa, F" uniqKey="Chiesa F" first="F." last="Chiesa">F. Chiesa</name>
</author>
<author>
<name sortKey="Lefebvre, J L" sort="Lefebvre, J L" uniqKey="Lefebvre J" first="J. L." last="Lefebvre">J. L. Lefebvre</name>
</author>
<author>
<name sortKey="Azul, A Mano" sort="Azul, A Mano" uniqKey="Azul A" first="A. Mano" last="Azul">A. Mano Azul</name>
</author>
<author>
<name sortKey="De Vries, N" sort="De Vries, N" uniqKey="De Vries N" first="N." last="De Vries">N. De Vries</name>
</author>
<author>
<name sortKey="Scully, C" sort="Scully, C" uniqKey="Scully C" first="C." last="Scully">C. Scully</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6285C86FE41880A49A3A76A1FB500602A9E625C5</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1016/0964-1955(95)00007-5</idno>
<idno type="url">https://api.istex.fr/document/6285C86FE41880A49A3A76A1FB500602A9E625C5/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003047</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003047</idno>
<idno type="wicri:Area/Istex/Curation">003047</idno>
<idno type="wicri:Area/Istex/Checkpoint">004C64</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">004C64</idno>
<idno type="wicri:doubleKey">0964-1955:1995:Boyle P:european:school:of</idno>
<idno type="wicri:Area/Main/Merge">00AC30</idno>
<idno type="wicri:Area/Main/Curation">00A627</idno>
<idno type="wicri:Area/Main/Exploration">00A627</idno>
<idno type="wicri:Area/France/Extraction">000460</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">European school of oncology advisory report to the European Commission for the Europe against cancer programme: Oral carcinogenesis in Europe</title>
<author>
<name sortKey="Boyle, P" sort="Boyle, P" uniqKey="Boyle P" first="P." last="Boyle">P. Boyle</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Italie</country>
<wicri:regionArea>P. Boyle, G.J. Macfarlane and F. Chiesa are at the European Institute of Oncology, via Ripamonti 435, 20141 Milan</wicri:regionArea>
<placeName>
<settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Macfarlane, G J" sort="Macfarlane, G J" uniqKey="Macfarlane G" first="G. J." last="Macfarlane">G. J. Macfarlane</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Italie</country>
<wicri:regionArea>P. Boyle, G.J. Macfarlane and F. Chiesa are at the European Institute of Oncology, via Ripamonti 435, 20141 Milan</wicri:regionArea>
<placeName>
<settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Blot, W J" sort="Blot, W J" uniqKey="Blot W" first="W. J." last="Blot">W. J. Blot</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>W.J. Blot is at the Division of Cancer Aetiology, National Cancer Institute, Bethesda, Maryland</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chiesa, F" sort="Chiesa, F" uniqKey="Chiesa F" first="F." last="Chiesa">F. Chiesa</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Italie</country>
<wicri:regionArea>P. Boyle, G.J. Macfarlane and F. Chiesa are at the European Institute of Oncology, via Ripamonti 435, 20141 Milan</wicri:regionArea>
<placeName>
<settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lefebvre, J L" sort="Lefebvre, J L" uniqKey="Lefebvre J" first="J. L." last="Lefebvre">J. L. Lefebvre</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>J.L. Lefebvre is at the Centre Oscar Lambert, Lille</wicri:regionArea>
<placeName>
<region type="region">Hauts-de-France</region>
<region type="old region">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Azul, A Mano" sort="Azul, A Mano" uniqKey="Azul A" first="A. Mano" last="Azul">A. Mano Azul</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>A. Mano Azul is at the Portuguese Academy of Oral Medicine, Lisbon</wicri:regionArea>
<wicri:noRegion>Lisbon</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Vries, N" sort="De Vries, N" uniqKey="De Vries N" first="N." last="De Vries">N. De Vries</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>N. de Vries is at the Free University Hospital, Amsterdam</wicri:regionArea>
<placeName>
<settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Scully, C" sort="Scully, C" uniqKey="Scully C" first="C." last="Scully">C. Scully</name>
<affiliation>
<wicri:noCountry code="subField">LondonUK</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">European Journal of Cancer. Part B: Oral Oncology</title>
<title level="j" type="abbrev">ORAONC</title>
<idno type="ISSN">0964-1955</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1995">1995</date>
<biblScope unit="volume">31</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="75">75</biblScope>
<biblScope unit="page" to="85">85</biblScope>
</imprint>
<idno type="ISSN">0964-1955</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0964-1955</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Advisory group</term>
<term>Aetiology</term>
<term>Alcohol consumption</term>
<term>Alcoholic beverages</term>
<term>Biomarkers</term>
<term>Boyle</term>
<term>Buccal mucosa</term>
<term>Cancer</term>
<term>Cancer causes control</term>
<term>Cancer development</term>
<term>Cancer incidence</term>
<term>Cancer mortality</term>
<term>Carcinogenesis</term>
<term>Carcinogenic risks</term>
<term>Carcinoma</term>
<term>Cell biochem</term>
<term>Chemoprevention</term>
<term>Chemoprevention agents</term>
<term>Chemoprevention studies</term>
<term>Chemoprevention trials</term>
<term>Chemopreventive</term>
<term>Chemopreventive agents</term>
<term>Chemopreventive intervention</term>
<term>Chemopreventive studies</term>
<term>Chemotherapy</term>
<term>Clinical trials</term>
<term>Complete remission</term>
<term>Control group</term>
<term>Control rate</term>
<term>Distant metastases</term>
<term>Early detection</term>
<term>Early lesions</term>
<term>Early stages</term>
<term>Eastern europe</term>
<term>Endpoint</term>
<term>Epidemiological studies</term>
<term>Epidemiology</term>
<term>Eurj cancer</term>
<term>European commission</term>
<term>European school</term>
<term>Experimental data</term>
<term>External radiotherapy</term>
<term>False positives</term>
<term>Further research</term>
<term>Further research work</term>
<term>Further work</term>
<term>Future treatment</term>
<term>General population</term>
<term>General rule</term>
<term>Genetic factors</term>
<term>Health problem</term>
<term>Herpes simplex virus</term>
<term>Herpes simplex viruses</term>
<term>High rates</term>
<term>High risk</term>
<term>Highest rates</term>
<term>Human papillomavirus</term>
<term>Iarc monograph</term>
<term>Ideal target</term>
<term>Incidence</term>
<term>Incidence rates</term>
<term>Induction chemotherapy</term>
<term>Inhibitory effect</term>
<term>Intermediate endpoints</term>
<term>International agency</term>
<term>Large study populations</term>
<term>Large tumours</term>
<term>Larger tumours</term>
<term>Lesion</term>
<term>Leukoplakia</term>
<term>Leukoplakias</term>
<term>Local control</term>
<term>Local control ranges</term>
<term>Lower gingiva</term>
<term>Lung cancer</term>
<term>Macfarlane</term>
<term>Malignant</term>
<term>Malignant disease</term>
<term>Malignant lesions</term>
<term>Malignant transformation</term>
<term>Mandible</term>
<term>Mandibular</term>
<term>Mandibular arch</term>
<term>Mandibular reconstruction</term>
<term>Mano azul</term>
<term>Many countries</term>
<term>Marginal mandibulectomy</term>
<term>Mentholated cigarettes</term>
<term>Mortality rates</term>
<term>Nat1 cancer inst</term>
<term>National cancer institute</term>
<term>Natural history</term>
<term>Neck cancer</term>
<term>Neck dissection</term>
<term>Normal mucosa</term>
<term>Nutrition intervention trials</term>
<term>Oesophageal dysplasia</term>
<term>Oncology</term>
<term>Oral</term>
<term>Oral cancer</term>
<term>Oral cancer epidemiology</term>
<term>Oral cancer mortality</term>
<term>Oral cancer patients</term>
<term>Oral cancer screening</term>
<term>Oral cancers</term>
<term>Oral carcinogenesis</term>
<term>Oral carcinoma</term>
<term>Oral cavity</term>
<term>Oral cavity cancer</term>
<term>Oral hygiene</term>
<term>Oral leukoplakia</term>
<term>Oral leukoplakias</term>
<term>Oral mucosa</term>
<term>Oral oncology</term>
<term>Oropharyngeal cancer</term>
<term>Palpable lymph node</term>
<term>Person years</term>
<term>Pharyngeal</term>
<term>Pharyngeal cancer</term>
<term>Pharyngeal cancers</term>
<term>Placebo</term>
<term>Positive margins</term>
<term>Postoperative radiotherapy</term>
<term>Premalignant</term>
<term>Premalignant lesion</term>
<term>Premalignant lesions</term>
<term>Present time</term>
<term>Primary prevention</term>
<term>Primary tumour</term>
<term>Programme</term>
<term>Radiotherapy</term>
<term>Radiotherapy modalities</term>
<term>Randomised</term>
<term>Randomised trial</term>
<term>Randomised trials</term>
<term>Remission</term>
<term>Resection</term>
<term>Retinoids</term>
<term>Retinyl palmitate</term>
<term>Risk factors</term>
<term>Salivary glands</term>
<term>Same factor</term>
<term>Screening</term>
<term>Screening programmes</term>
<term>Screening test</term>
<term>Screening tests</term>
<term>Scully</term>
<term>Second primaries</term>
<term>Serum vitamin</term>
<term>Side effects</term>
<term>Similar trends</term>
<term>Smokeless tobacco</term>
<term>Smoking tobacco</term>
<term>Squamous</term>
<term>Squamous cell carcinoma</term>
<term>Such increases</term>
<term>Superficial lesions</term>
<term>Surgical resection</term>
<term>Survival rates</term>
<term>Tobacco smoking</term>
<term>Tumour</term>
<term>Tumour resection</term>
<term>Vitamin</term>
<term>Vitamin supplement</term>
<term>Young adults</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Advisory group</term>
<term>Aetiology</term>
<term>Alcohol consumption</term>
<term>Alcoholic beverages</term>
<term>Biomarkers</term>
<term>Boyle</term>
<term>Buccal mucosa</term>
<term>Cancer</term>
<term>Cancer causes control</term>
<term>Cancer development</term>
<term>Cancer incidence</term>
<term>Cancer mortality</term>
<term>Carcinogenesis</term>
<term>Carcinogenic risks</term>
<term>Carcinoma</term>
<term>Cell biochem</term>
<term>Chemoprevention</term>
<term>Chemoprevention agents</term>
<term>Chemoprevention studies</term>
<term>Chemoprevention trials</term>
<term>Chemopreventive</term>
<term>Chemopreventive agents</term>
<term>Chemopreventive intervention</term>
<term>Chemopreventive studies</term>
<term>Chemotherapy</term>
<term>Clinical trials</term>
<term>Complete remission</term>
<term>Control group</term>
<term>Control rate</term>
<term>Distant metastases</term>
<term>Early detection</term>
<term>Early lesions</term>
<term>Early stages</term>
<term>Eastern europe</term>
<term>Endpoint</term>
<term>Epidemiological studies</term>
<term>Epidemiology</term>
<term>Eurj cancer</term>
<term>European commission</term>
<term>European school</term>
<term>Experimental data</term>
<term>External radiotherapy</term>
<term>False positives</term>
<term>Further research</term>
<term>Further research work</term>
<term>Further work</term>
<term>Future treatment</term>
<term>General population</term>
<term>General rule</term>
<term>Genetic factors</term>
<term>Health problem</term>
<term>Herpes simplex virus</term>
<term>Herpes simplex viruses</term>
<term>High rates</term>
<term>High risk</term>
<term>Highest rates</term>
<term>Human papillomavirus</term>
<term>Iarc monograph</term>
<term>Ideal target</term>
<term>Incidence</term>
<term>Incidence rates</term>
<term>Induction chemotherapy</term>
<term>Inhibitory effect</term>
<term>Intermediate endpoints</term>
<term>International agency</term>
<term>Large study populations</term>
<term>Large tumours</term>
<term>Larger tumours</term>
<term>Lesion</term>
<term>Leukoplakia</term>
<term>Leukoplakias</term>
<term>Local control</term>
<term>Local control ranges</term>
<term>Lower gingiva</term>
<term>Lung cancer</term>
<term>Macfarlane</term>
<term>Malignant</term>
<term>Malignant disease</term>
<term>Malignant lesions</term>
<term>Malignant transformation</term>
<term>Mandible</term>
<term>Mandibular</term>
<term>Mandibular arch</term>
<term>Mandibular reconstruction</term>
<term>Mano azul</term>
<term>Many countries</term>
<term>Marginal mandibulectomy</term>
<term>Mentholated cigarettes</term>
<term>Mortality rates</term>
<term>Nat1 cancer inst</term>
<term>National cancer institute</term>
<term>Natural history</term>
<term>Neck cancer</term>
<term>Neck dissection</term>
<term>Normal mucosa</term>
<term>Nutrition intervention trials</term>
<term>Oesophageal dysplasia</term>
<term>Oncology</term>
<term>Oral</term>
<term>Oral cancer</term>
<term>Oral cancer epidemiology</term>
<term>Oral cancer mortality</term>
<term>Oral cancer patients</term>
<term>Oral cancer screening</term>
<term>Oral cancers</term>
<term>Oral carcinogenesis</term>
<term>Oral carcinoma</term>
<term>Oral cavity</term>
<term>Oral cavity cancer</term>
<term>Oral hygiene</term>
<term>Oral leukoplakia</term>
<term>Oral leukoplakias</term>
<term>Oral mucosa</term>
<term>Oral oncology</term>
<term>Oropharyngeal cancer</term>
<term>Palpable lymph node</term>
<term>Person years</term>
<term>Pharyngeal</term>
<term>Pharyngeal cancer</term>
<term>Pharyngeal cancers</term>
<term>Placebo</term>
<term>Positive margins</term>
<term>Postoperative radiotherapy</term>
<term>Premalignant</term>
<term>Premalignant lesion</term>
<term>Premalignant lesions</term>
<term>Present time</term>
<term>Primary prevention</term>
<term>Primary tumour</term>
<term>Programme</term>
<term>Radiotherapy</term>
<term>Radiotherapy modalities</term>
<term>Randomised</term>
<term>Randomised trial</term>
<term>Randomised trials</term>
<term>Remission</term>
<term>Resection</term>
<term>Retinoids</term>
<term>Retinyl palmitate</term>
<term>Risk factors</term>
<term>Salivary glands</term>
<term>Same factor</term>
<term>Screening</term>
<term>Screening programmes</term>
<term>Screening test</term>
<term>Screening tests</term>
<term>Scully</term>
<term>Second primaries</term>
<term>Serum vitamin</term>
<term>Side effects</term>
<term>Similar trends</term>
<term>Smokeless tobacco</term>
<term>Smoking tobacco</term>
<term>Squamous</term>
<term>Squamous cell carcinoma</term>
<term>Such increases</term>
<term>Superficial lesions</term>
<term>Surgical resection</term>
<term>Survival rates</term>
<term>Tobacco smoking</term>
<term>Tumour</term>
<term>Tumour resection</term>
<term>Vitamin</term>
<term>Vitamin supplement</term>
<term>Young adults</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Cancer</term>
<term>épidémiologie</term>
<term>école européenne</term>
<term>Vitamine</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: A European School of Oncology Advisory Group has reviewed current knowledge on the epidemiology, treatment and prevention of cancer of the oral cavity. While the major factors in the aetiology of such cancers are thought to be well understood, i.e. tobacco and alcohol consumption, current increases in the occurrence of the disease, especially in young adults throughout Europe, are cause for concern. The reasons for such increases are not clearly evident and the Advisory Group has suggested further work which is required to be carried out to understand the aetiology. In treatment of the disease there have been no major improvements in survival for patients in recent decades and the importance of examining new radiotherapy modalities and defining the role of chemotherapy is emphasized. Primary prevention of oral cancer could be achieved by stopping smoking tobacco, limiting alcohol consumption to a minimum (2–3 drinks per day) and increasing intake of fruits and vegetables. To supplement these actions, while neither population screening programmes nor screening trials could be recommended by the Advisory Group, initial chemoprevention trials have produced some promising results and this represents an interesting area which is the focus of much current research.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>Italie</li>
<li>Pays-Bas</li>
<li>Portugal</li>
<li>États-Unis</li>
</country>
<region>
<li>Hauts-de-France</li>
<li>Hollande-Septentrionale</li>
<li>Lombardie</li>
<li>Maryland</li>
<li>Nord-Pas-de-Calais</li>
</region>
<settlement>
<li>Amsterdam</li>
<li>Lille</li>
<li>Milan</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Scully, C" sort="Scully, C" uniqKey="Scully C" first="C." last="Scully">C. Scully</name>
</noCountry>
<country name="Italie">
<region name="Lombardie">
<name sortKey="Boyle, P" sort="Boyle, P" uniqKey="Boyle P" first="P." last="Boyle">P. Boyle</name>
</region>
<name sortKey="Chiesa, F" sort="Chiesa, F" uniqKey="Chiesa F" first="F." last="Chiesa">F. Chiesa</name>
<name sortKey="Macfarlane, G J" sort="Macfarlane, G J" uniqKey="Macfarlane G" first="G. J." last="Macfarlane">G. J. Macfarlane</name>
</country>
<country name="États-Unis">
<region name="Maryland">
<name sortKey="Blot, W J" sort="Blot, W J" uniqKey="Blot W" first="W. J." last="Blot">W. J. Blot</name>
</region>
</country>
<country name="France">
<region name="Hauts-de-France">
<name sortKey="Lefebvre, J L" sort="Lefebvre, J L" uniqKey="Lefebvre J" first="J. L." last="Lefebvre">J. L. Lefebvre</name>
</region>
</country>
<country name="Portugal">
<noRegion>
<name sortKey="Azul, A Mano" sort="Azul, A Mano" uniqKey="Azul A" first="A. Mano" last="Azul">A. Mano Azul</name>
</noRegion>
</country>
<country name="Pays-Bas">
<region name="Hollande-Septentrionale">
<name sortKey="De Vries, N" sort="De Vries, N" uniqKey="De Vries N" first="N." last="De Vries">N. De Vries</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000460 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000460 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:6285C86FE41880A49A3A76A1FB500602A9E625C5
   |texte=   European school of oncology advisory report to the European Commission for the Europe against cancer programme: Oral carcinogenesis in Europe
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022